Can Intravenous Ketamine Reduce Risk for Postpartum Depression?
Intravenous ketamine at delivery reduced risk for postpartum depression; however, only in women at high risk for PPD.
Intravenous ketamine at delivery reduced risk for postpartum depression; however, only in women at high risk for PPD.
SAGE-547 (SAGE Therapeutics) is a new drug, an allosteric modulator of GABAA receptors, which is currently under investigation for the treatment of refractory seizure disorders. Â It turns out that SAGE-547 may also be useful for [...]